Search Page

1

Cite

CD45 in human physiology and clinical medicine.

Rheinländer A, Schraven B, Bommhardt U. Rheinländer A, et al. Among authors: bommhardt u. Immunol Lett. 2018 Apr;196:22-32. doi: 10.1016/j.imlet.2018.01.009. Epub 2018 Jan 31. Immunol Lett. 2018. PMID: 29366662 Review.

Cite

2

Cite

Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy.

Bommhardt U, Schraven B, Simeoni L. Bommhardt U, et al. Int J Mol Sci. 2019 Jul 16;20(14):3500. doi: 10.3390/ijms20143500. Int J Mol Sci. 2019. PMID: 31315298 Free PMC article. Review.

Cite

3

Cite

Age-related increase of VGF-expression in T lymphocytes.

Busse S, Steiner J, Micheel J, Dobrowolny H, Mawrin C, Krause TJ, Adamaszek M, Bogerts B, Bommhardt U, Hartig R, Busse M. Busse S, et al. Among authors: bommhardt u. Aging (Albany NY). 2014 Jun;6(6):440-53. doi: 10.18632/aging.100656. Aging (Albany NY). 2014. PMID: 25013207 Free PMC article.

Cite

4

Cite

Thymocyte-derived BDNF influences T-cell maturation at the DN3/DN4 transition stage.

Linker RA, Lee DH, Flach AC, Litke T, van den Brandt J, Reichardt HM, Lingner T, Bommhardt U, Sendtner M, Gold R, Flügel A, Lühder F. Linker RA, et al. Among authors: bommhardt u. Eur J Immunol. 2015 May;45(5):1326-38. doi: 10.1002/eji.201444985. Epub 2015 Feb 19. Eur J Immunol. 2015. PMID: 25627579 Free article.

Cite

5

Cite

VGF expression by T lymphocytes in patients with Alzheimer's disease.

Busse S, Steiner J, Glorius S, Dobrowolny H, Greiner-Bohl S, Mawrin C, Bommhardt U, Hartig R, Bogerts B, Busse M. Busse S, et al. Among authors: bommhardt u. Oncotarget. 2015 Jun 20;6(17):14843-51. doi: 10.18632/oncotarget.3569. Oncotarget. 2015. PMID: 26142708 Free PMC article.

Cite

6

Cite

Type of PaperY192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection.

Kästle M, Merten C, Hartig R, Plaza-Sirvent C, Schmitz I, Bommhardt U, Schraven B, Simeoni L. Kästle M, et al. Among authors: bommhardt u. Int J Mol Sci. 2022 Jun 30;23(13):7271. doi: 10.3390/ijms23137271. Int J Mol Sci. 2022. PMID: 35806279 Free PMC article.

Cite

7

Cite

An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development.

Patra AK, Avots A, Zahedi RP, Schüler T, Sickmann A, Bommhardt U, Serfling E. Patra AK, et al. Among authors: bommhardt u. Nat Immunol. 2013 Feb;14(2):127-35. doi: 10.1038/ni.2507. Epub 2012 Dec 23. Nat Immunol. 2013. PMID: 23263556

Cite

8

Cite

Proteasome inhibition potentiates Kv1.3 potassium channel expression as therapeutic target in drug-sensitive and -resistant human melanoma cells.

Cammann C, Kulla J, Wiebusch L, Walz C, Zhao F, Lowinus T, Topfstedt E, Mishra N, Henklein P, Bommhardt U, Bossaller L, Hagemeier C, Schadendorf D, Schmidt B, Paschen A, Seifert U. Cammann C, et al. Among authors: bommhardt u. Biomed Pharmacother. 2023 Dec;168:115635. doi: 10.1016/j.biopha.2023.115635. Epub 2023 Oct 8. Biomed Pharmacother. 2023. PMID: 37816303 Free article.

Cite

9

Cite

NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells.

Simma N, Bose T, Kahlfuss S, Mankiewicz J, Lowinus T, Lühder F, Schüler T, Schraven B, Heine M, Bommhardt U. Simma N, et al. Among authors: bommhardt u. Cell Commun Signal. 2014 Dec 5;12:75. doi: 10.1186/s12964-014-0075-5. Cell Commun Signal. 2014. PMID: 25477292 Free PMC article.

Cite

10

Cite

NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network.

Bhattacharyya S, Deb J, Patra AK, Thuy Pham DA, Chen W, Vaeth M, Berberich-Siebelt F, Klein-Hessling S, Lamperti ED, Reifenberg K, Jellusova J, Schweizer A, Nitschke L, Leich E, Rosenwald A, Brunner C, Engelmann S, Bommhardt U, Avots A, Müller MR, Kondo E, Serfling E. Bhattacharyya S, et al. Among authors: bommhardt u. J Exp Med. 2011 Apr 11;208(4):823-39. doi: 10.1084/jem.20100945. Epub 2011 Apr 4. J Exp Med. 2011. PMID: 21464221 Free PMC article.

Cite